Form 4: Lenz Therapeutics Executive Shawn Olsson Acquires Stock Options Following Merger

Chief Commercial Officer Shawn Olsson acquired stock options in Lenz Therapeutics following the merger with Generate Merger Sub, Inc.

Summary

• On March 21, 2024, Shawn Olsson, Chief Commercial Officer of Lenz Therapeutics, acquired stock options as a result of the merger with Generate Merger Sub, Inc.
• The options were granted in exchange for outstanding options to purchase shares of LENZ OpCo, pursuant to the terms and conditions of the Merger Agreement.
• Olsson now directly owns options to purchase 67,974 shares at $2.08, 30,466 shares at $5.05, 50,915 shares at $6.04 and 105,000 shares at $15.05.
• The options vest over time, contingent on Olsson's continued service with the company.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The granting of stock options to a key executive is a common practice and suggests confidence in the company's future. However, it's not a major event that would drastically alter the company's outlook.

Positives

• The acquisition of stock options by a key executive suggests confidence in the company's future performance.

Risks

• The value of the stock options is dependent on the future performance of Lenz Therapeutics' stock price.
• The vesting of the options is contingent on Olsson's continued employment, creating a potential risk if he were to leave the company.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting schedules of the options suggest a multi-year commitment from the executive.

Industry Context

Stock option grants are a common practice in the pharmaceutical industry to incentivize and retain key executives, aligning their interests with those of the shareholders.

Comparison to Industry Standards

• Stock option grants are a standard component of executive compensation packages in the biotech and pharmaceutical industries.
• Companies like Alcon, Bausch + Lomb, and Novartis also utilize stock options as part of their compensation strategy to attract and retain talent.
• The vesting schedules and exercise prices are generally in line with industry norms for similar-stage companies.

Stakeholder Impact

• The granting of stock options aligns the interests of the executive with those of the shareholders, potentially leading to increased shareholder value.

Key Dates